Laboratory-acquired Pneumonic Plague
Authors: R. W. BURMEISTER
Journal: Annals of Internal Medicine (1962)

Case Reports1 May 1962Laboratory-acquired Pneumonic PlagueReport of a Case and Review of Previous CasesR. W. BURMEISTER, M.D., W. D. TIGERTT, M.D., F.A.C.P., E. L. OVERHOLT, M.D., F.A.C.P.R. W. BURMEISTER, M.D., W. D. TIGERTT, M.D., F.A.C.P., E. L. OVERHOLT, M.D., F.A.C.P.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-56-5-789 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptPneumonic plague is one of the most important pestilential diseases and until recently had the highest fatality rate of any epidemic disease.The more common bubonic plague is acquired by transfer ofPasteurella pestisfrom the rat or wild rodent reservoir by ectoparasite vectors, usually the flea. Occasionally, a severe bubonic case develops secondary pneumonic manifestations. It is the consensus that this is the origin of a pneumonic plague outbreak with subsequent cases resulting from the inhalation of fomites (1). When contrasted to the reputed high incidence of pneumonic plague in contacts under natural conditions, the low incidence of disease...References1. POLLITZER R: Plague, World Health Organization, Monograph Series No. 22, Geneva, 1954. Google Scholar2. LAWTONFUKUISURGALLA WDGMMJ: Studies on the antigens of Pasteurella pestis and Pasteurella pseudotuberculosis. J. Immunol. 84: 475, 1960. MedlineGoogle Scholar3. WU LT: A Treatise on Pneumonic Plague, League of Nations, Geneva, 1926. Google Scholar4. LINK VB: A History of Plague in the United States, United States Public Health Service Monograph No. 26, 1955. Google Scholar5. MUNTER EJ: Pneumonic plague; report of a case with recovery. J. A. M. A. 128: 281, 1945. CrossrefGoogle Scholar6. HUANGHUANGCHUHUANG CHCYLWTF: Pneumonic plague; a report of recovery in a proved case and a note on sulfadiazine prophylaxis. Amer. J. Trop. Med. 28: 361, 1948. CrossrefMedlineGoogle Scholar7. LEWINBECKERHORWITZ WBJB: Two cases of pneumonic plague; recovery of one case treated with streptomycin. S. Afr. Med. J. 22: 699, 1948. Google Scholar8. TIEHLANDAUERMIYAGAWAKOBAYASHIOKAYASU THEFGG: Primary pneumonic plague in Mukden, 1946 and report of 39 cases with 3 recoveries. J. Infect. Dis. 82: 52, 1948. CrossrefMedlineGoogle Scholar9. MITRA A: The plague in Kashmir. Indian Med. Gazette 42: 133, 1907. MedlineGoogle Scholar10. WYNNE-GRIFFITH G: Pneumonic plague in Rangoon. Lancet 1: 625, 1948. CrossrefMedlineGoogle Scholar11. MURDOCK JR: Pneumonic plague in Ecuador during 1939. Pub. Health Rep. 55: 2172, 1940. CrossrefGoogle Scholar12. WUCHUNPOLLITZERWU LTJWRCY: Plague; A Manual for Medical and Public Health Workers, Weishengshu National Quarantine Service, Shanghai Station, Shanghai, 1936. Google Scholar13. STRONG RP: Studies on pneumonic plague and plague immunization. Philipp. J. Sci. 7 (sec. B): 131, 1912. Google Scholar14. STRONG RP: Stitt's Diagnosis, Prevention and Treatment of Tropical Diseases, 7th ed. The Blakiston Company, Philadelphia, 1944, chap. 18. Google Scholar15. DICKIE WM: Plague in California 1900-1925, in Proceedings of the Conference of the State and Provincial Health Authorities of North America, vol. 3, American Health Congress Series, State Board of Health, St. Paul, Minnesota, 1926, pp. 30-78. Google Scholar16. MEYERQUANMCCRUMBLARSON KFSFFRA: Effective treatment of plague. Ann. N. Y. Acad. Sci. 55: 1228, 1952. CrossrefMedlineGoogle Scholar17. MEYERQUANLARSON KFSFA: Prophylactic immunization and specific therapy of experimental pneumonic plague. Amer. Rev. Tuberc. 57: 312, 1948. Google Scholar18. Expert Committee on Plague, Third Report, World Health Organization Technical Report Series No. 165, Geneva, 1959. Google Scholar19. ESTRADE F: Premiers cas de guerison de peste pulmonaire primitive par la streptomycine. Progr. Med. (Par.) 59: 328, 1951. Google Scholar20. LLOYD BJ: Plague—past, present and future. J. A. M. A. 85: 729, 1925. CrossrefGoogle Scholar21. MCCRUMBMERCIERROBICBOUILLATSMADELWOODWARDGOODNER FRSJMJETEK: Chloramphenicol and terramycin in the treatment of pneumonic plague. Amer. J. Med. 14: 284, 1953. CrossrefMedlineGoogle Scholar22. CLARKGOLDBERG BMS: Pneumonic plague; recovery in a proved case. S. Afr. Med. J. 17: 57, 1943. Google Scholar23. MERCIERMCCRUMB SFR: Premiere guerison d'un cas de peste pulmonaire par la chloromyectine. Med. Trop. (Marseille) 12: 693, 1952. MedlineGoogle Scholar24. MERCIERMCCRUMB SFR: Premieres guerisons de cas de peste pulmonaire traites par la terramycine. Med. Trop. (Marseille) 12: 698, 1952. MedlineGoogle Scholar25. SMADELWOODWARDAMIESGOODNER JETECRK: Antibiotics in the treatment of bubonic and pneumonic plague in man. Ann. N. Y. Acad. Sci. 55: 1275, 1952. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Frederick, MarylandFrom the United States Army Medical Unit, Walter Reed Army Medical Center, Fort Detrick, Maryland.Requests for reprints should be addressed to Lieutenant Colonel Edwin L. Overholt, (MC), Department of Medicine, Walter Reed General Hospital, Washington 12, D. C. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe African Green Monkey Model of Pneumonic Plague and US Food and Drug Administration Approval of Antimicrobials Under the Animal RuleYersiniaYersinia Species (Including Plague)Development of real-time PCR assays for specific detection of hmsH, hmsF, hmsR, and irp2 located within the 102-kb pgm locus of Yersinia pestisBacterial PathogensOccupational InfectionsPrimary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluationPlaguePlague as a Bioterrorism WeaponFacing highly infectious diseases: new trends and current conceptsInfection control in the management of highly pathogenic infectious diseases: consensus of the European Network of Infectious DiseasePlaguePlagueBacterial InfectionsPneumonic Plague Cluster, Uganda, 2004Risk of Person‐to‐Person Transmission of Pneumonic PlagueRisk of Occupationally Acquired Illnesses from Biological Threat Agents in Unvaccinated Laboratory WorkersAnthrax, tularemia, plague, ebola or smallpox as agents of bioterrorism: recognition in the emergency roomThe Pathology of Community-Acquired PneumoniaPlagueHistory & Epidemiology of Laboratory-Acquired Infections (in Relation to the Cancer Research Program)Hantavirus pulmonary syndrome: Recognition and emergency department managementBacterial InfectionsSafety in microbiology: an overviewPlagueOverwhelming PneumoniaPlagueComparison of the Reliability and Sensitivity of Three Serological Procedures in Detecting Antibody to Yersinia pestis (Pasteurella pestis)Potential Medical Problems in Personnel Returning from VietnamDAVID N. GILBERT, WILLIAM L. MOORE JR., CHARLES L. HEDBERG, JAY P. SANFORD, M.D., F.A.C.P.PestAgar-Gel Precipitin-Inhibition Technique for Plague Antibody Determinations 1 May 1962Volume 56, Issue 5_Part_1Page: 789-800KeywordsAntigensBacterial pneumoniaFleasInhalationInoculationPlaguePneumoniaResearch laboratoriesThorax Issue Published: 1 May 1962 PDF downloadLoading ...